Sign in

CIK 0000872589

  • Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
133444607
Phone
+1 914-847-7000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
  1. 4 Shares withheld for taxes EVP Research gave up 492 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP Commercial gave up 274 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP General Counsel and Secret gave up 492 shares (to pay taxes)
  4. 4 Gift EVP Research gave 1,185 shares (gift)
  5. 4 Planned sale EVP Commercial sold 1,000 shares at $844.61 ($844,610)
  6. 4 Planned sale Director sold 100 shares at an average $1,048.78 ($104,878)
  7. 4 Planned sale EVP Commercial sold 1,000 shares at $1,054.06 ($1,054,060)
  8. 4 Gift Director gave 1,200 shares (gift)
  9. 4 Planned sale EVP Commercial sold 1,000 shares at $1,178.73 ($1,178,730)
  10. 4 Planned sale Director sold 100 shares at an average $1,178.69 ($117,869)
  11. 4 Open-market sale SVP Finance & CFO sold 5,680 shares at an average $1,205.33 ($6,846,262)
  12. 4 Planned sale Director sold 756 shares at $1,170.00 ($884,520)
  13. 4 Open-market sale Director sold 10,838 shares at an average $1,158.17 ($12,552,285)
  14. 4 Planned sale EVP Research sold 6,363 shares at an average $1,153.15 ($7,337,505)
  15. 4 Gift EVP Research and Development gave 500 shares (gift)
  16. 4 Planned sale EVP Research and Development sold 5,197 shares at an average $1,084.54 ($5,636,346)
  17. 4 Open-market sale VP Controller sold 487 shares at $1,070.00 ($521,090)
  18. 4 Shares withheld for taxes EVP Research and Development gave up 18,441 shares (to pay taxes)
  19. 4 Planned sale Director sold 756 shares at $1,115.00 ($842,940)
  20. 4 Planned sale EVP Commercial sold 1,137 shares at $1,060.86 ($1,206,198)

Page 5 of 77 · 1,533 filings